Arrowhead Pharmaceuticals
ARWR
#2055
Rank
A$13.93 B
Marketcap
A$99.56
Share price
0.30%
Change (1 day)
207.70%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total assets

Total assets on the balance sheet as of September 2025 : A$1.98 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total assets are A$1.98 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Arrowhead Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-09-30A$2.09 B27.15%
2024-09-30A$1.64 B38.38%
2023-09-30A$1.19 B10.71%
2022-09-30A$1.07 B9.54%
2021-09-30A$0.98 B34.7%
2020-09-30A$0.72 B40.74%
2019-09-30A$0.51 B235.31%
2018-09-30A$0.15 B16.53%
2017-09-30A$0.13 B-20.99%
2016-09-30A$0.16 B-11.06%
2015-09-30A$0.18 B-9.82%
2014-09-30A$0.20 B422.42%
2013-09-30A$40.05 M150.94%
2012-09-30A$15.96 M-2.14%
2011-09-30A$16.3 M27.32%
2010-09-30A$12.81 M44.44%
2009-09-30A$8.86 M-59.28%
2008-09-30A$21.78 M-34.74%
2007-09-30A$33.37 M-27.88%
2006-09-30A$46.28 M21.03%
2005-09-30A$38.23 M130.05%
2004-09-30A$16.62 M644.09%
2003-09-30A$2.23 M1810.72%
2002-09-30A$0.11 M24.19%
2001-09-30A$0.09 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$276.88 B 13,818.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
A$17.42 B 775.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$2.12 B 6.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$6.96 B 250.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
A$99.63 M-94.99%๐Ÿ‡บ๐Ÿ‡ธ USA